CLINICAL_TRIALS ClinicalTrials.gov record update

Pilot Study of Pembrolizumab in Untreated Extranodal, NK/T Cell Lymphoma, Nasal Type

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03728972
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:01.115747+00:00
Published At: 2025-10-23T00:00:00+00:00
Record Updated At: 2025-10-23
Results Posted At: 2025-10-23
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["NK/T-Cell Lymphoma of Nasal Cavity (Diagnosis)", "NK/T-Cell Lymphoma of Nasopharynx (Diagnosis)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-10-23"
protocolSection.identificationModule.nctId: "NCT03728972"
protocolSection.identificationModule.officialTitle: "Pilot Study of Pembrolizumab in Untreated Extranodal, NK/T Cell Lymphoma, Nasal Type"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-10-23"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.